Jones D - Search Results

1

A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA.

Schattenberg JM, Pares A, Kowdley KV, Heneghan MA, Caldwell S, Pratt D, Bonder A, Hirschfield GM, Levy C, Vierling J, Jones D, Tailleux A, Staels B, Megnien S, Hanf R, Magrez D, Birman P, Luketic V. Schattenberg JM, et al. Among authors: jones d. J Hepatol. 2021 Jun;74(6):1344-1354. doi: 10.1016/j.jhep.2021.01.013. Epub 2021 Jan 21. J Hepatol. 2021. PMID: 33484775 Free article. Clinical Trial.

2

T-cell responses to the components of pyruvate dehydrogenase complex in primary biliary cirrhosis.

Jones DE, Palmer JM, James OF, Yeaman SJ, Bassendine MF, Diamond AG. Jones DE, et al. Hepatology. 1995 Apr;21(4):995-1002. Hepatology. 1995. PMID: 7705811

3

Ursodeoxycholic acid therapy in primary biliary cirrhosis.

Jones DE, James OF, Bassendine MF. Jones DE, et al. Hepatology. 1995 May;21(5):1469-73. doi: 10.1002/hep.1840210535. Hepatology. 1995. PMID: 7737655 Clinical Trial. No abstract available.

4

Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.

Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF. Jones DE, et al. Hepatology. 1997 Nov;26(5):1138-42. doi: 10.1002/hep.510260508. Hepatology. 1997. PMID: 9362353

5

No evidence for involvement of the interleukin-10 -592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis.

Zappala F, Grove J, Watt FE, Daly AK, Day CP, Bassendine MF, Jones DE. Zappala F, et al. Among authors: jones de. J Hepatol. 1998 May;28(5):820-3. doi: 10.1016/s0168-8278(98)80232-8. J Hepatol. 1998. PMID: 9625317

6

Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.

Jones DE, Watt FE, Grove J, Newton JL, Daly AK, Gregory WL, Day CP, James OF, Bassendine MF. Jones DE, et al. J Hepatol. 1999 Feb;30(2):232-6. doi: 10.1016/s0168-8278(99)80067-1. J Hepatol. 1999. PMID: 10068101

7

Familial primary biliary cirrhosis reassessed: a geographically-based population study.

Jones DE, Watt FE, Metcalf JV, Bassendine MF, James OF. Jones DE, et al. J Hepatol. 1999 Mar;30(3):402-7. doi: 10.1016/s0168-8278(99)80097-x. J Hepatol. 1999. PMID: 10190721

8

Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis.

Palmer JM, Jones DE, Quinn J, McHugh A, Yeaman SJ. Palmer JM, et al. Among authors: jones de. Hepatology. 1999 Jul;30(1):21-6. doi: 10.1002/hep.510300106. Hepatology. 1999. PMID: 10385634

9

Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.

Jones DE, James OF, Portmann B, Burt AD, Williams R, Hudson M. Jones DE, et al. Hepatology. 1999 Jul;30(1):53-7. doi: 10.1002/hep.510300103. Hepatology. 1999. PMID: 10385638

10

Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis.

Jones DE, Palmer JM, Yeaman SJ, Kirby JA, Bassendine MF. Jones DE, et al. Hepatology. 1999 Jul;30(1):65-70. doi: 10.1002/hep.510300123. Hepatology. 1999. PMID: 10385640

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,497 results

Search Page

Filters